Intravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy is the fastest way of delivering the fluids to different parts of the body. In cases, wherein the patient requires rapid medication, such as heart attack, stroke, and poisoning, IV medication is preferred. Some of the drugs administered intravenously are chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, drugs for low blood pressure, and others. IV therapy operates with a rapid speed, ease to monitor, and avoids side effects on gastrointestinal systems.
Increase in prevalence of diseases, such as cardiac disorders, blood pressure, cancer; and increase in road accidents drive the market growth. In addition, growth in surgical procedures, rise in trauma cases, rapid technological advancements, increase in awareness among the population, and surge in geriatric population fuel the market further. However, high risk of allergic reaction is expected to restrain the growth of the market during the forecast period. The global intravenous therapy and vein access market has accounted for $18,000 million in 2016, and is estimated to reach $27,971 million by 2023, growing at a CAGR of 6.4% during the forecast period.
The market is segmented on the basis of product type, medical application, end user, and geography. By product type, it is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. Medical applications covered in the study include volume expanders, medication administration, blood-based products, and nutrition & buffer solution. Based on end user, it is classified into hospitals, ambulatory surgical centers, and clinics. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STKEHOLDERS
The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
Implantable Ports
Single Lumen Implantable Port
Double Lumen Implantable Port
Intravenous Catheters
Peripheral Intravenous Catheter
Central Intravenous Catheter
Peripherally Inserted Central Catheter
Hypodermic Needles
Infusion Pumps
Other Products
By Medical Application
Volume Expanders
Medication Administration
Blood-based Products
Nutrition & Buffer Solution
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
List of players profiled in the report
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Medical Corporation
Teleflex Medical Inc.
Medtronic Inc.
Smith & Nephew plc.
AngioDynamics, Inc.
Pfizer Inc.
Insulet Corporation
Fresenius SE & Co. KGaA
List of other players (These companies are not profiled in the report and same can be done on demand)
iRadimed Corporation
Baxter International Inc.
BioScrip, Inc.
Grifols, S.A.
JW Life Science Co. Ltd.
BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
CVS Health Corporation
Vifor Pharma Group
